Wordt geladen...
Prevalence of Anti-Adeno-Associated Virus Immune Responses in International Cohorts of Healthy Donors
Preexisting immunity against adeno-associated virus (AAV) is a major challenge facing AAV gene therapy, resulting in the exclusion of patients from clinical trials. Accordingly, proper assessment of anti-AAV immunity is necessary for understanding clinical data and for product development. Previous...
Bewaard in:
Gepubliceerd in: | Mol Ther Methods Clin Dev |
---|---|
Hoofdauteurs: | , , , , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
American Society of Gene & Cell Therapy
2019
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6629972/ https://ncbi.nlm.nih.gov/pubmed/31338384 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2019.05.014 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|